Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-02-21
2006-02-21
Li, Q. Janice (Department: 1632)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S320100, C435S069100, C424S093210, C514S04400A
Reexamination Certificate
active
07001995
ABSTRACT:
Synthetic DNA molecules encoding papillomavirus proteins are provided. The codons of the synthetic molecules are codons preferred by the projected host cell. The synthetic molecules may be used as a polynucleotide vaccine which provides effective immunoprophylaxis against papillomavirus infection through stimulation of neutralizing antibody and cell-mediated immunity.
REFERENCES:
patent: 5679509 (1997-10-01), Wheeler et al.
patent: 5820870 (1998-10-01), Joyce et al.
patent: 5874304 (1999-02-01), Zolotukhin et al.
patent: 5952216 (1999-09-01), Ludmerer
patent: 6019978 (2000-02-01), Ertl et al.
patent: 6123948 (2000-09-01), Whittle et al.
patent: 6159729 (2000-12-01), Hofmann et al.
patent: 6399383 (2002-06-01), Apt et al.
patent: 6489141 (2002-12-01), Frazer et al.
patent: WO 96/00583 (1996-11-01), None
patent: WO 96/39178 (1996-12-01), None
patent: WO 9902694 (1999-01-01), None
Donnelly et al. Protection against papillomavirus with a polynuicleotide vaccine pp. 314-320 1996.
Bodey et al. Failure of cancer vaccines. The significant limitations of this approach to immunotherapy pp. 2665-2676 2000.
McCluskie et al. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates 1999.
Orkin et al. Report and recommendations of the panel to assess the NIH investment in research on gene therapy pp. 1-41 1995.
Rudinger Characteristics of the amino acids as components of a peptide hormone sequence pp. 1-8 1976.
Bowie et al. Deciphering the message in protein sequences: tolerance to amino acid substitutions vol. 247 1990.
Chemical compound Mar. 8, 2001.
Moingeon et al. Challenges and issues in new vaccine development pp. 173-175 vol. 23 No. 4 2002.
Bubenik, J. Int. J. Oncol 2002;20:207.
Nakano et al. J Virol 1997;71:7101-09.
He, Z., et al. Viral Recombinant Vaccines to the E6 and E7 Antigens of HPV-16, VIROLOGY. 270. 146-161, 2000.
Toes, R. E. M., et al, Protective Anti-Tumor Immunity . . . in a String of Beads Fashion, Proc. Natl. Acad. Scie. USA, vol. 94. pp. 14660-14665. Dec. 1997.
Borysiewicz, L. K., et al., A Recombinant Vaccinia Encoding Human Papillomavirus Types 16 and 18, E6 and E7 Proteins as Immunotherapy for Cervical Cancer, The Lancet, vol. 347, p. 1523-1527, Jun. 1, 1996.
Nimako, M. et al., Human Papillomavirus-specific Cytotoxic T Lymphocytes in Patients with Cervical Intraepithelial Neoplasia Grade III. Cancer Research, vol. 57, p. 4855-4861, Nov. 1, 1997.
Smahel, M., et al., DNA Vaccine Against Oncogenic Hamster Cells . . . Activated ras Oncogene, Oncology Reports vol. 6. p. 211-215, 1999.
Xu, Jianqing et al. Human Papillomavirus 16 7-specific CTL Induction through Mouse B7-1 Costiumulating with E7C Subgene Chin J. Microbiol Immunol. vol. 19, No. 3, p 227-231.
Kotecha, M. T., et al., Humoral Response Induced by Vaccination with Plasmid DNA Containing the HPV16 LI ORF IMMUNOLOGY vol. 95, No. Suppl. 1, p. 107, 1998.
Afghan, R.K., et al., Immune Responses Induced by Vaccination With Plasmid DNA Containing The HPV16 E7 ORF IMMUNOLOGY vol. 95, No. Suppl. 1, p. 106, 1998.
Zhou, Jian et al., Papillomavirus Capsid Protein Expression . . . and tRNA Availability, Jour of Virology, vol. 73, No. 6, p. 4972-4982, Jun. 1999.
Chen, C. H., et al. Boosting with Recombinant Vaccinia . . . expressing DNA Vaccines, VACCINE, vol. 18, p. 2015-2022, 2000.
Lathe, “Synthetic Oligonucleotide Probes Deduced from Amino Acid Sequence Data”, J. Mol. Biol., vol. 183, pp. 1-12, 1985.
De Pasquale, et al., “Modulation of HPV16 E7 Translation by tRNAs in Eukaryotic Cell-Free Translation Systems”, Biochemistry and Molecular Biology International, vol. 45, No. 5, pp. 1005-1009, Aug. 1998.
Pasquala et al; vol. No. 5, 1998 Biochemistry and Molecular Biology International, pp. 1005-1009.
Chen Ling
Jansen Kathrin U.
McClements William L.
Neeper Michael P
Schultz Loren D.
Finnegan Alysia A.
Giesser Joanne M.
Li Q. Janice
Merck & Co. , Inc.
LandOfFree
Synthetic human papillomavirus genes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic human papillomavirus genes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic human papillomavirus genes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3680229